Document is current
Any future updates will be listed below
-
Authors
Wang, Zichen
Xiao, Zhihan
Zhang, Tongyu
Lu, Meiyou
Li, Hai
Cao, Jing
Zheng, Jianan
Zhou, Yichan
Dai, Juncheng
Wang, Cheng
Chen, Liang
Xu, Jing
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81972175)
Hengrui Medical Clinical Research Foundation of Collaborative Innovation Center for Cancer Personalized Medicine (2024-02)
Clinical Capacity Enhancement Project of the First Affiliated Hospital of Nanjing Medical University (2021-02)
- License Information
-
More Information
Article History
Received: 28 April 2024
Accepted: 14 January 2025
First Online: 23 January 2025
Declarations
:
: The study was approved by the Ethics Committee of The First Affiliated Hospital of Nanjing Medical University (Protocol code: 2022-SR-055. Approval date: 20 January 2022). All experiments on humans and/or the use of human tissue samples strictly adhered to the Declaration of Helsinki.
: Consent to publish has been obtained from all authors.
: The authors declare no competing interests.
